Pictet Asset Management Holding Sa Summit Therapeutics Inc. Call Options Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding SMMT
# of Institutions
232Shares Held
85.7MCall Options Held
1.7MPut Options Held
2.92M-
Baker Bros. Advisors LP New York, NY24.4MShares$576 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$274 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$186 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$155 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$114 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.74B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...